Pancreatic Cancer Research

ResearcherUniversity Hospital Southampton NHS Foundation TrustActive in the last 2 years

Ali Raza Arshad

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6596-7835; OpenAlex author ID A5028912750. Sources: OpenAlex.

Their work

Papers
14 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 2 papers · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 4 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers

Papers 14

  1. The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study. Co-author DOI 10.1016/j.annonc.2024.12.015↗
  2. Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: an international multicentre retrospectiv… Last author DOI 10.1016/j.hpb.2024.11.015↗
  3. The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study. Co-author DOI 10.1038/s41416-023-02220-2↗
  4. Proteomic Characterization of Circulating Molecular Perturbations Associated With Pancreatic Adenocarcinoma Following Intravenous ω-3 Fatty Acid and Gemcitabin… First author DOI 10.1002/jpen.1952↗
  5. Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. Co-author DOI 10.1016/j.hpb.2021.03.003↗
  6. Comment on "Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position". Co-author DOI 10.1038/s41416-020-01132-9↗
  7. Intraoperative radiotherapy for pancreatic cancer: implementation and initial experience. Co-author DOI 10.1093/bjs/znab335↗
  8. Myeloid derived suppressor cells are reduced and T regulatory cells stabilised in patients with advanced pancreatic cancer treated with gemcitabine and intrave… First author DOI 10.21037/atm.2020.02.02↗
  9. Endothelial Progenitor Cells are Increased in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine and Intravenous Omega 3 Compared with Controls First author DOI 10.21203/rs.3.rs-36878/v1↗
  10. Cellular and plasma uptake of parenteral omega-3 rich lipid emulsion fatty acids in patients with advanced pancreatic cancer. Co-author DOI 10.1016/j.clnu.2013.09.017↗
  11. Restoration of mannose-binding lectin complement activity is associated with improved outcome in patients with advanced pancreatic cancer treated with gemcitab… Co-author DOI 10.1177/0148607113476304↗
  12. Pooled survival and response data from phase III randomized controlled trials for gemcitabine-based regimes in the treatment of advanced pancreatic cancer. Co-author DOI 10.1097/coc.0b013e3182124216↗
  13. Reduction in circulating pro-angiogenic and pro-inflammatory factors is related to improved outcomes in patients with advanced pancreatic cancer treated with g… Co-author DOI 10.1111/hpb.12002↗
  14. Potential applications of fish oils rich in n-3 fatty acids in the palliative treatment of advanced pancreatic cancer. Co-author DOI 10.1017/s0007114511003060↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ashley Robert Dennison · 9 shared papers, 2011–2021 · strength 0.74
  2. John Isherwood · 5 shared papers, 2014–2021 · strength 0.45
  3. Franscois Runau · 3 shared papers, 2020–2021 · strength 0.35
  4. Wen Yuan Chung · 5 shared papers, 2013–2020 · strength 0.35
  5. John M. Primrose · 2 shared papers, 2021 · strength 0.31
  6. Mark Taylor · 1 shared paper, 2021 · strength 0.17
  7. Donald J. L. Jones · 1 shared paper, 2021 · strength 0.15
  8. Arjun S. Takhar · 1 shared paper, 2021 · strength 0.13
  9. Rahul Bhome · 1 shared paper, 2021 · strength 0.13
  10. Dimitrios D. Karavias · 1 shared paper, 2021 · strength 0.13
  11. Zaed Z. R. Hamady · 1 shared paper, 2021 · strength 0.13
  12. Iain Stephen Tait · 1 shared paper, 2021 · strength 0.08
  13. Duncan R.C. Spalding · 1 shared paper, 2021 · strength 0.08
  14. James Michael Halle-Smith · 1 shared paper, 2021 · strength 0.08
  15. Jawad Elsayed Ahmad · 1 shared paper, 2021 · strength 0.08
  16. Nicola de Liguori Carino · 1 shared paper, 2021 · strength 0.08
  17. Giuseppe Garcea · 1 shared paper, 2021 · strength 0.08
  18. Andreas A. Prachalias · 1 shared paper, 2021 · strength 0.08
  19. Samir Pathak · 1 shared paper, 2021 · strength 0.08
  20. Robert Peter Sutcliffe · 1 shared paper, 2021 · strength 0.08
  21. Sivesh Kathir Kamarajah · 1 shared paper, 2021 · strength 0.08
  22. Stephen J. Wigmore · 1 shared paper, 2021 · strength 0.08
  23. Ricky Harminder Bhogal · 1 shared paper, 2021 · strength 0.08
  24. Somaiah Aroori · 1 shared paper, 2021 · strength 0.08
  25. Bilal A. Al-Sarireh · 1 shared paper, 2021 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.